Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $184 at Morgan Stanley; 'Adjusting Model for Biosimilar Neulasta Delay'

June 13, 2017 7:34 AM
Morgan Stanley raised its price target on Amgen (NASDAQ: AMGN) to $184.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change FDA

Next Articles